证券记录 · 已归档季度
JAZZ
Jazz Pharmaceuticals plc · Healthcare · Biotechnology
15被追踪持有人
0Δ持有人
8.56M持有股份
$1.05B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -8.5% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 23.86K | $4.65M | +1 | −3 |
| Q2 2026 | 135 | +4 | 47.42M | $11.41B | +7 | −4 |
| Q1 2026 | 135 | -10 | 49.63M | $8.67B | +4 | −14 |
| Q4 2025 | 144 | +2 | 48.56M | $7.62B | +2 | n/a |
| Q3 2025 | 20 | 0 | 25.68M | $3.38B | +1 | −1 |
| Q2 2025 | 17 | -1 | 21.49M | $2.28B | +1 | −2 |
| Q1 2025 | 15 | 0 | 8.34M | $1.04B | +1 | −1 |
| Q4 2024 | 15 | 0 | 8.56M | $1.05B | +1 | −1 |
| Q3 2024 | 14 | -2 | 7.38M | $822.21M | n/a | −2 |
| Q2 2024 | 16 | n/a | 7.74M | $826.28M | n/a | n/a |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 1.97M | n/a | $242.46M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Capital World Investors ✦ | 1.92M | +5.7% | $236.86M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (被动) | 1.09M | -1.9% | $134.70M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 4 | Renaissance Technologies ✦ | 1.00M | -4.6% | $123.38M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 5 | Millennium Management ✦ | 611.29K | -6.2% | $75.28M | 0.1% | ▼ Trim | 3 | SEC ↗ ×2 |
| 6 | AQR Capital Management ✦ | 533.68K | -3.6% | $65.72M | 0.1% | ▼ Trim | 3 | SEC ↗ ×2 |
| 7 | Citadel Advisors ✦ | 506.35K | -51.9% | $62.36M | 0.1% | ▼ Trim | 3 | SEC ↗ ×2 |
| 8 | D. E. Shaw & Co. ✦ | 302.11K | +16.9% | $37.20M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 9 | Bridgewater Associates ✦ | 192.03K | +69.9% | $23.65M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 187.13K | -41.5% | $23.04M | 0.1% | ▼ Trim | 3 | SEC ↗ ×2 |
| 11 | Point72 Asset Management ✦ | 84.15K | -68.7% | $10.36M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 12 | Marshall Wace ✦ | 59.38K | 新增 | $7.31M | 0.0% | New | 1 | SEC ↗ ×2 |
| 13 | Wellington Management ✦ | 41.80K | -6.8% | $5.15M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 14 | T. Rowe Price ✦ | 38.18K | +2.8% | $4.70M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 15.09K | -28.2% | $1.86M | 0.0% | ▼ Trim | 3 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $7.31M | 0.0% |
已清仓
| Arrowstreet Capital | $8.50M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 568 持有人, 63.82M 股份, $11.28B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 06
GALA RENEE D
Officer, Director · 2.00K 股 · $472,800
Oct 01
COZADD BRUCE C
Director · 6.00K 股 · $1.38M
Sep 10
Patil Neena M
Officer · 1.20K 股 · $289,128
Sep 08
GALA RENEE D
Officer · 2.00K 股 · $486,060
Sep 01
COZADD BRUCE C
Director · 6.00K 股 · $1.50M
Aug 27
Iannone Robert
Officer · 300 股 · $75,828
Aug 27
Iannone Robert
Officer · 18.11K 股 · $4.53M
Aug 27
Iannone Robert
Officer · 9.26K 股 · $2.33M
Aug 27
Iannone Robert
Officer · 11.42K 股 · $2.84M
Aug 27
Iannone Robert
Officer · 18.19K 股 · $4.51M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 06
SC 13G: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据